Abivax (ABVX) Equity Ratio (2023 - 2026)

Abivax's Equity Ratio history runs 4 years deep, the most recent figure standing at 0.79 for Q1 2026.

• In Q1 2026, Equity Ratio rose 2088.38% year-over-year to 0.79; the TTM figure through Mar 2026 stood at 0.79 (up 2088.38% YoY), while the FY2025 annual figure was 0.78, up 293.72% from the prior year.
• Equity Ratio was 0.79 for Q1 2026 at Abivax, up from 0.78 in the prior quarter.
• In the past five years, Equity Ratio ranged from a high of 0.79 in Q1 2026 to a low of 0.4 in Q2 2025.
• Historically, Equity Ratio has averaged 0.39 across 4 years, with a median of 0.52 in 2024.
• The sharpest annual moves came in 2025 and 2026: Equity Ratio plunged 190.78% in 2025, then surged 2088.38% in 2026.
• A 4-year view of Equity Ratio shows it stood at 0.6 in 2023, then tumbled by 66.99% to 0.2 in 2024, then soared by 293.72% to 0.78 in 2025, then climbed by 0.79% to 0.79 in 2026.
• The last three Equity Ratio figures came in at 0.79 (Q1 2026), 0.78 (Q4 2025), and 0.78 (Q3 2025), per Business Quant data.